Lumakras (sotorasib tablets - Amgen) — Cigna
Small Bowel Adenocarcinoma
Initial criteria
- Patient age ≥ 18 years
- Patient has advanced or metastatic disease
- Patient has KRAS G12C mutation-positive disease
- Medication will be used as subsequent therapy
Approval duration
1 year